UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance can link PPI‐responsive heartburn to reflux better than acid exposure time

Neurogastroenterology and motility, 2017-11, Vol.29 (11), p.n/a

2017

Volltextzugriff (PDF)

The added diagnostic value of postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on‐therapy impedance‐pH monitoring

Neurogastroenterology and motility, 2017-03, Vol.29 (3), p.np-n/a

2017

Volltextzugriff (PDF)

Esophageal chemical clearance is impaired in gastro‐esophageal reflux disease – a 24‐h impedance‐pH monitoring assessment

Neurogastroenterology and motility, 2013-05, Vol.25 (5), p.399-e295

2013

Volltextzugriff (PDF)

Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn

Neurogastroenterology and motility, 2014-04, Vol.26 (4), p.546-555

2014

Volltextzugriff (PDF)

Neoplastic progression in short‐segment Barrett's oesophagus is associated with impairment of chemical clearance, but not inadequate acid suppression by proton pump inhibitor therapy

Alimentary pharmacology & therapeutics, 2014-10, Vol.40 (7), p.835-842

2014

Volltextzugriff (PDF)

Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD

Alimentary pharmacology & therapeutics, 2011-07, Vol.34 (1), p.67-75

2011

Volltextzugriff (PDF)

Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD

Neurogastroenterology and motility, 2016-02, Vol.28 (2), p.243-250

2016

Volltextzugriff (PDF)

Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor‐resistant reflux oesophagitis

Alimentary pharmacology & therapeutics, 2011-03, Vol.33 (5), p.601-606

2011

Volltextzugriff (PDF)

Characteristics of gastro‐esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers

Neurogastroenterology and motility, 2010-10, Vol.22 (10), p.1061-e280

2010

Volltextzugriff (PDF)

The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn

Neurogastroenterology and motility, 2012-02, Vol.24 (2), p.141-e87

2012

Volltextzugriff (PDF)

Reflux patterns in patients with short‐segment Barrett’s oesophagus: a study using impedance‐pH monitoring off and on proton pump inhibitor therapy

Alimentary pharmacology & therapeutics, 2009-09, Vol.30 (5), p.508-515

2009

Volltextzugriff (PDF)

Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non‐erosive reflux disease

Alimentary pharmacology & therapeutics, 2003-12, Vol.18 (11‐12), p.1091-1098

2003

Volltextzugriff (PDF)

Pathophysiological characteristics of patients with non‐erosive reflux disease differ from those of patients with functional heartburn

Alimentary pharmacology & therapeutics, 2004-07, Vol.20 (1), p.81-88

2004

Volltextzugriff (PDF)

Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?

Digestive and liver disease, 2006-09, Vol.38 (9), p.643-648

2006

Volltextzugriff (PDF)

Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra‐oesophageal acid suppression

Alimentary pharmacology & therapeutics, 2002-05, Vol.16 (5), p.881-886

2002

Volltextzugriff (PDF)

Fingerprint ridge distance computation methodologies

Pattern recognition, 2000, Vol.33 (1), p.69-80

2000

Volltextzugriff (PDF)

Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors

Digestive and liver disease, 2007-05, Vol.39 (5), p.415-421

2007

Volltextzugriff (PDF)

Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer

Gastrointestinal endoscopy, 2015-08, Vol.82 (2), p.337-343

2015

Volltextzugriff (PDF)

Effective intra‐oesophageal acid suppression in patients with gastro‐oesophageal reflux disease: lansoprazole vs. pantoprazole

Alimentary pharmacology & therapeutics, 2003-01, Vol.17 (2), p.235-241

2003

Volltextzugriff (PDF)

Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole

Digestive and liver disease, 2006-02, Vol.38 (2), p.85-90

2006

Volltextzugriff (PDF)

Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis

Gastrointestinal endoscopy, 2017-07, Vol.86 (1), p.74-86.e17

2017

Volltextzugriff (PDF)

A multimodal, one-session endoscopic approach for management of patients with advanced pancreatic cancer

Surgical endoscopy, 2016-05, Vol.30 (5), p.1863-1868

2016

Volltextzugriff (PDF)

Lansoprazole vs. omeprazole for gastro‐oesophageal reflux disease: a pH‐metric comparison

Alimentary pharmacology & therapeutics, 2002-01, Vol.16 (1), p.35-39

2002

Volltextzugriff (PDF)

Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison

Digestive and liver disease, 2002-02, Vol.34 (2), p.99-104

2002

Volltextzugriff (PDF)

Development of a prediction model of adverse events after stent placement for esophageal cancer

Gastrointestinal endoscopy, 2016-04, Vol.83 (4), p.746-752

2016

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Humans
(37)
Gastroenterology & Hepatology
(32)
Male
(26)
Middle Aged
(26)
Female
(23)
Adult
(15)
Biological And Medical Sciences
(14)
Aged
(13)
Hydrogen-Ion Concentration
(13)
Medical Sciences
(13)
Gastroesophageal Reflux - Physiopathology
(12)
Manometry
(10)
Clinical Neurology
(9)
Gastroenterology. Liver. Pancreas. Abdomen
(9)
Gastroesophageal Reflux - Drug Therapy
(9)
Neurosciences
(9)
Neurosciences & Neurology
(9)
Pharmacology & Pharmacy
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance can link PPI‐responsive heartburn to reflux better than acid exposure time

The added diagnostic value of postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on‐therapy impedance‐pH monitoring

Esophageal chemical clearance is impaired in gastro‐esophageal reflux disease – a 24‐h impedance‐pH monitoring assessment

Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn

Neoplastic progression in short‐segment Barrett's oesophagus is associated with impairment of chemical clearance, but not inadequate acid suppression by proton pump inhibitor therapy

Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD

Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD

Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor‐resistant reflux oesophagitis

Characteristics of gastro‐esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers

The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn

Reflux patterns in patients with short‐segment Barrett’s oesophagus: a study using impedance‐pH monitoring off and on proton pump inhibitor therapy

Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non‐erosive reflux disease

Pathophysiological characteristics of patients with non‐erosive reflux disease differ from those of patients with functional heartburn

Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?

Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra‐oesophageal acid suppression

Fingerprint ridge distance computation methodologies

Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors

Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer

Effective intra‐oesophageal acid suppression in patients with gastro‐oesophageal reflux disease: lansoprazole vs. pantoprazole

Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole

Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis

A multimodal, one-session endoscopic approach for management of patients with advanced pancreatic cancer

Lansoprazole vs. omeprazole for gastro‐oesophageal reflux disease: a pH‐metric comparison

Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison

Development of a prediction model of adverse events after stent placement for esophageal cancer

Aktive Filter

Suchergebnisse filtern